Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Distress Tolerance vs. Relaxation Therapy for Benzodiazepine Discontinuation in Patients Receiving Opioid Agonist Therapy

NCT05250570 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT05250570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Distress Tolerance vs. Relaxation Therapy for Benzodiazepine Discontinuation in Patients Receiving Opioid Agonist Therapy
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Terminated
Start date
June 17, 2022
Completion date
December 9, 2022
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorders